Haowen Tan

4PUBLICATIONS
3CO-AUTHORS
Medical infection agents (incl. prions)AutoimmunityAllergyInstrumental methods (excl. immunological and bioassay methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 17, 2026
Post-marketing safety assessment of mirvetuximab soravtansine: a disproportionality analysis based on the FDA Adverse Event Reporting System.

|Nov 24, 2025
A Pharmacovigilance Study of Immune Checkpoint Inhibitor-Associated Cholangitis: Insights From the FDA Adverse Event Reporting System.

Haowen Tan, Xuan Ou, Ying Chen

|Oct 26, 2024
Immune checkpoint inhibitor-associated bullous pemphigoid: A retrospective and real-world study based on the United States Food and Drug Administration adverse event reporting system.

Haowen Tan, Xiubi Chen, Ying Chen

|Jul 25, 2024
Cytokine release syndrome associated with immune checkpoint inhibitors: a pharmacovigilance study based on spontaneous reports in FAERS.

Xin Xi, Xida Yan, Ying Chen

Pageof 1

Frequent Collaborators

2 joint publications

Luping Luo

1 joint publications

Xuan Ou

1 joint publications

Ying Chen